Amarin Corp Plc\Uk (AMRN) Research & Development (2010 - 2026)
Amarin Corp Plc\Uk (AMRN) reported Research & Development of $4.21 million for Q3 2026, down 0.1% from $4.21 million a year earlier and down 11.9% from the prior quarter.
Powered by 
Analysis
Amarin Corp Plc\Uk (AMRN) Research & Development (2010 - 2026) Analysis & Trends
Over the twelve months ended Sep 30, 2026, Amarin Corp Plc\Uk's Research & Development came in at $19.01 million, down 6.9% year-over-year; for FY2025, it came in at $19.81 million, down 5.1% from FY2024.
- Research & Development has declined for three consecutive years, with a five-year compound annual growth rate of -12.7% (FY2020 to FY2025).
- By year, Research & Development came in at $20.87 million in FY2024 (-6.1%), $22.22 million in FY2023 (-26.9%), $30.41 million in FY2022 (+3.8%) and $29.31 million in FY2021 (-24.8%).
- The Q3 2026 figure ranks as the lowest quarterly Research & Development in data going back to Q2 2010.
- Year over year, Research & Development has now declined in each of the last five quarters, with an average decline of 3.9% over the last eight quarters.
- The high point for year-over-year Research & Development in five years was Q2 2022 (growth of 47.2%); the low point was Q1 2023 (a decline of 43.5%).
- Per Business Quant data, the three quarters before Q3 2026 came in at $4.77 million (Q2 2026), $4.67 million (Q1 2026) and $5.37 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 4.25 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 4.65 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 2.57 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 4.54 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 2.11 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 1.61 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 3.02 Bn |
| 10 | Amarin Corp Plc\Uk | 4.92 Bn | 3.67 Bn | 16.18 Mn | 4.21 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 4.21 Mn |
| Jun 30, 2026 | 4.77 Mn |
| Mar 31, 2026 | 4.67 Mn |
| Dec 31, 2025 | 5.37 Mn |
| Sep 30, 2025 | 4.21 Mn |
| Jun 30, 2025 | 4.92 Mn |
| Mar 31, 2025 | 5.31 Mn |
| Dec 31, 2024 | 5.99 Mn |
| Sep 30, 2024 | 4.54 Mn |
| Jun 30, 2024 | 4.75 Mn |
| Mar 31, 2024 | 5.60 Mn |
| Dec 31, 2023 | 5.79 Mn |
| Sep 30, 2023 | 5.11 Mn |
| Jun 30, 2023 | 5.64 Mn |
| Mar 31, 2023 | 5.68 Mn |
| Dec 31, 2022 | 5.24 Mn |
| Sep 30, 2022 | 5.77 Mn |
| Jun 30, 2022 | 9.36 Mn |
| Mar 31, 2022 | 10.05 Mn |
| Dec 31, 2021 | 5.75 Mn |
API Access
Amarin Corp Plc\Uk Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=AMRN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "AMRN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=AMRN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();